A double-blind, placebo-controlled phase 1/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1.
Journal
Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086
Informations de publication
Date de publication:
20 05 2020
20 05 2020
Historique:
received:
19
09
2019
accepted:
22
04
2020
entrez:
22
5
2020
pubmed:
22
5
2020
medline:
24
6
2021
Statut:
ppublish
Résumé
Immunization with attenuated
Identifiants
pubmed: 32434847
pii: 12/544/eaaz5629
doi: 10.1126/scitranslmed.aaz5629
pii:
doi:
Substances chimiques
Malaria Vaccines
0
Vaccines, Attenuated
0
Types de publication
Clinical Trial, Phase I
Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : R44 AI069631
Pays : United States
Informations de copyright
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.